FDA Review of Pfizer Covid-19 Vaccine for Kids Expected

U.S. health regulators are expected to weigh in soon on the evidence for giving the Covid-19 vaccine from Pfizer Inc. and BioNTech SE to children 5 to 11 years old.

The U.S. Food and Drug Administration is expected as early as Friday morning to post online its written assessment of study data submitted by the companies. In early October, Pfizer and BioNTech asked the FDA to authorize the vaccine for children 5 to 11 years old.


Leave a Reply

Your email address will not be published. Required fields are marked *

scroll to top